Dr. Larry Wedell Warner Jr., MD

Dr. Warner practices at Collaborative Minds in Hammond, Louisiana.

Dr. Warner's NPI, 1851552806, was assigned on June 23, 2008. Dr. Warner holds Louisiana license 203545.

Dr. Warner's primary practice is Collaborative Minds, at 1250 SW Railroad Ave, Hammond, LA 70403 in Tangipahoa Parish. The practice phone is (225) 456-2884.

Dr. Warner's primary practice is Collaborative Minds in Hammond, Louisiana. Dr. Warner is also affiliated with PeaceHealth St. John Medical Center. The medical group on file is Our Lady of the Lake Physician Group. Dmand AI also links Dr. Warner to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Warner practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Warner's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dmand AI has Dr. Warner's licenses on file in 2 states: Louisiana and Washington.

CMS data shows 173 Medicare services from Dr. Warner across 2 procedure codes in 2024, for 59 Medicare patients. Medicare paid $9,044 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 59 Medicare patients who saw Dr. Warner in 2024. The largest group is under 65, with 41 patients. 75% of them have anxiety, and 75% have high blood pressure. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Warner's median patient age at 39, with 55% women.

In 2024, Dr. Warner wrote 891 Medicare Part D claims for 69 patients. 97% of them were for generic drugs. CMS names the drug for 817 of them, across 25 drugs with 11 or more claims each, at $44,418 in total drug cost. In 2023, CMS named 857 claims across 24 drugs.

Dr. Warner accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1,021 general payments to Dr. Warner from 18 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 76% of the total. Neurocrine BioSciences, Inc. paid the most, $472,430.